Characteristics and outcomes of patients treated with sotrovimab to prevent progression to severe COVID-19 in Belgium.

Myriam DrysdaleThor HautekietMoushmi SinghJoris HautekietLinda LudikhuyzeVishal PatelDaniel C GibbonsDorothée De RoeckKirsten ColpaertEmily J LloydEva Van Braeckel

Published in: Acta clinica Belgica (2024)

This study indicated low rates of COVID-19-related hospitalisations and all-cause deaths in sotrovimab-treated patients in Belgium, including during Omicron subvariant periods, despite over two-thirds of the study population being immunocompromised.

Keyphrases

coronavirus disease
sars cov
intensive care unit
skeletal muscle
weight loss
drug induced
acute respiratory distress syndrome
mechanical ventilation